{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:23:39Z","timestamp":1795029819223,"version":"4.10.2"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["275SIL"],"award-info":[{"award-number":["275SIL"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["275SIL"],"award-info":[{"award-number":["275SIL"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["275SIL"],"award-info":[{"award-number":["275SIL"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The diagnostic journey for many rare disease patients remains challenging despite use of latest genetic technological advancements. We hypothesize that some patients remain undiagnosed due to more complex diagnostic scenarios that are currently not considered in genome analysis pipelines. To better understand this, we characterized the rare disorder (RD) spectrum using various bioinformatics resources (e.g., Orphanet\/Orphadata, Human Phenotype Ontology, Reactome pathways) combined with custom-made R scripts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our in silico characterization led to identification of 145 borderline-common, 412 rare and 2967 ultra-rare disorders. Based on these findings and point prevalence, we would expect that approximately 6.53%, 0.34%, and 0.30% of individuals in a randomly selected population have a borderline-common, rare, and ultra-rare disorder, respectively (equaling to 1 RD patient in 14 people). Importantly, our analyses revealed that (1) a higher proportion of borderline-common disorders were caused by multiple gene defects and\/or other factors compared with the rare and ultra-rare disorders, (2) the phenotypic expressivity was more variable for the borderline-common disorders than for the rarer disorders, and (3) unique clinical characteristics were observed across the disorder categories forming the spectrum.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Recognizing that RD patients who remain unsolved even after genome sequencing might belong to the more common end of the RD spectrum support the usage of computational pipelines that account for more complex genetic and phenotypic scenarios.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-022-02217-9","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T08:02:45Z","timestamp":1645516965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Rare disorders have many faces: in silico characterization of rare disorder spectrum"],"prefix":"10.1186","volume":"17","author":[{"given":"Simona D.","family":"Frederiksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Avramovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Maroilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Arbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4472-8584","authenticated-orcid":false,"given":"Maja","family":"Tarailo-Graovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"2217_CR1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/0929867324666170718101946","volume":"25","author":"A Fernandez-Marmiesse","year":"2018","unstructured":"Fernandez-Marmiesse A, Gouveia S, Couce ML. NGS technologies as a turning point in rare disease research. Diagnosis Treat Curr Med Chem. 2018;25:404\u201332.","journal-title":"Diagnosis Treat Curr Med Chem"},{"key":"2217_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drudis.2017.11.002","volume":"23","author":"RE Pogue","year":"2018","unstructured":"Pogue RE, Cavalcanti DP, Shanker S, Andrade RV, Aguiar LR, de Carvalho JL, et al. Rare genetic diseases: update on diagnosis, treatment and online resources. Drug Discov Today. 2018;23:187\u201395.","journal-title":"Drug Discov Today"},{"key":"2217_CR3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/cge.12732","volume":"89","author":"J Thevenon","year":"2016","unstructured":"Thevenon J, Duffourd Y, Masurel-Paulet A, Lefebvre M, Feillet F, El Chehadeh-Djebbar S, et al. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test. Clin Genet. 2016;89:700\u20137.","journal-title":"Clin Genet"},{"key":"2217_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrg.2017.116","volume":"19","author":"CF Wright","year":"2018","unstructured":"Wright CF, FitzPatrick DR, Firth HV. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet. 2018;19:253\u201368.","journal-title":"Nat Rev Genet"},{"key":"2217_CR5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ng.3827","volume":"49","author":"DR FitzPatrick","year":"2017","unstructured":"FitzPatrick DR. Resequencing at scale in neurodevelopmental disorders. Nat Genet. 2017;49:488\u20139.","journal-title":"Nat Genet"},{"key":"2217_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature13394","volume":"511","author":"C Gilissen","year":"2014","unstructured":"Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BWM, Willemsen MH, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511:344\u20137. https:\/\/doi.org\/10.1038\/nature13394.","journal-title":"Nature"},{"key":"2217_CR7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archinte.165.13.1493","volume":"165","author":"ML Graber","year":"2005","unstructured":"Graber ML, Franklin N, Gordon R. Diagnostic error in internal medicine. Arch Intern Med. 2005;165:1493\u20139.","journal-title":"Arch Intern Med"},{"key":"2217_CR8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00001888-200210000-00009","volume":"77","author":"M Graber","year":"2002","unstructured":"Graber M, Gordon R, Franklin N. Reducing diagnostic errors in medicine: what\u2019s the goal? Acad Med. 2002;77:981\u201392.","journal-title":"Acad Med"},{"key":"2217_CR9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajmg.1320050203","volume":"5","author":"P Janku","year":"1980","unstructured":"Janku P, Robinow M, Kelly T, Bralley R, Baynes A, Edgerton MT. The van der Woude syndrome in a large kindred: variability, penetrance, genetic risks. Am J Med Genet. 1980;5:117\u201323.","journal-title":"Am J Med Genet"},{"key":"2217_CR10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00439-013-1331-2","volume":"132","author":"DN Cooper","year":"2013","unstructured":"Cooper DN, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet. 2013;132:1077\u2013130.","journal-title":"Hum Genet"},{"key":"2217_CR11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/bies.200900066","volume":"31","author":"JK Ahluwalia","year":"2009","unstructured":"Ahluwalia JK, Hariharan M, Bargaje R, Pillai B, Brahmachari V. Incomplete penetrance and variable expressivity: is there a microRNA connection? BioEssays. 2009;31:981\u201392.","journal-title":"BioEssays"},{"key":"2217_CR12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41436-020-01021-9","volume":"23","author":"CF Wright","year":"2021","unstructured":"Wright CF, Eberhardt RY, Constantinou P, Hurles ME, FitzPatrick DR, Firth HV. Evaluating variants classified as pathogenic in ClinVar in the DDD Study. Genet Med. 2021;23:571\u20135.","journal-title":"Genet Med"},{"key":"2217_CR13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrg2809","volume":"11","author":"EE Eichler","year":"2010","unstructured":"Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet. 2010;11:446\u201350.","journal-title":"Nat Rev Genet"},{"key":"2217_CR14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/genes10040275","volume":"10","author":"T Maroilley","year":"2019","unstructured":"Maroilley T, Tarailo-Graovac M. Uncovering missing heritability in rare diseases. Genes (Basel). 2019;10:275.","journal-title":"Genes (Basel)."},{"key":"2217_CR15","first-page":"65","volume":"5","author":"V Plaiasu","year":"2010","unstructured":"Plaiasu V, Nanu M, Matei D. Rare disease day-at a glance. Maedica (Buchar). Media Med Publicis. 2010;5:65\u20136.","journal-title":"Media Med Publicis"},{"key":"2217_CR16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"S Nguengang Wakap","year":"2020","unstructured":"Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28:165\u201373.","journal-title":"Eur J Hum Genet"},{"key":"2217_CR17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nrg2897","volume":"11","author":"D Houle","year":"2010","unstructured":"Houle D, Govindaraju DR, Omholt S. Phenomics: the next challenge. Nat Rev Genet. 2010;11:855\u201366.","journal-title":"Nat Rev Genet"},{"key":"2217_CR18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrg1826","volume":"7","author":"SE Antonarakis","year":"2006","unstructured":"Antonarakis SE, Beckmann JS. Mendelian disorders deserve more attention. Nat Rev Genet. 2006;7:277\u201382.","journal-title":"Nat Rev Genet"},{"key":"2217_CR19","doi-asserted-by":"crossref","unstructured":"Nabbout R, Scheffer IE. Genetics of idiopathic epilepsies. In: Dulac O, Lassonde M, Sarnat HBBT-H of CN, editors. Handb Clin Neurol. Elsevier; 2013. p. 567\u201378. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780444528919000592.","DOI":"10.1016\/B978-0-444-52891-9.00059-2"},{"key":"2217_CR20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/cge.13150","volume":"93","author":"C Deltas","year":"2018","unstructured":"Deltas C. Digenic inheritance and genetic modifiers. Clin Genet. 2018;93:429\u201338.","journal-title":"Clin Genet"},{"key":"2217_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/genes11030239","volume":"11","author":"KMTH Rahit","year":"2020","unstructured":"Rahit KMTH, Tarailo-Graovac M. Genetic modifiers and rare mendelian disease. Genes (Basel). 2020;11:239.","journal-title":"Genes (Basel)."},{"key":"2217_CR22","unstructured":"Mukherjee S, Cogan JD, Newman JH, Phillips JA, Hamid R, Meiler J, et al. Identifying digenic disease genes using machine learning in the undiagnosed diseases network. bioRxiv. 2020;2020.05.31.125716. Available from: http:\/\/biorxiv.org\/content\/early\/2020\/06\/01\/2020.05.31.125716.abstract."},{"key":"2217_CR23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajhg.2018.12.015","volume":"104","author":"CF Wright","year":"2019","unstructured":"Wright CF, West B, Tuke M, Jones SE, Patel K, Laver TW, et al. Assessing the pathogenicity, penetrance, and expressivity of putative disease-causing variants in a population setting. Am J Hum Genet. 2019;104:275\u201386.","journal-title":"Am J Hum Genet"},{"key":"2217_CR24","doi-asserted-by":"crossref","first-page":"a017145","DOI":"10.1101\/cshperspect.a017145","volume":"5","author":"M Kousi","year":"2015","unstructured":"Kousi M, Katsanis N. Genetic modifiers and oligogenic inheritance. Cold Spring Harb Perspect Med. 2015;5:a017145.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2217_CR25","doi-asserted-by":"crossref","first-page":"D900","DOI":"10.1093\/nar\/gkv1068","volume":"44","author":"AM Gazzo","year":"2016","unstructured":"Gazzo AM, Daneels D, Cilia E, Bonduelle M, Abramowicz M, Van Dooren S, et al. DIDA: a curated and annotated digenic diseases database. Nucleic Acids Res. 2016;44:D900\u20137.","journal-title":"Nucleic Acids Res"},{"key":"2217_CR26","doi-asserted-by":"publisher","first-page":"W93","DOI":"10.1093\/nar\/gkz437","volume":"47","author":"A Renaux","year":"2019","unstructured":"Renaux A, Papadimitriou S, Versbraegen N, Nachtegael C, Boutry S, Now\u00e9 A, et al. ORVAL: a novel platform for the prediction and exploration of disease-causing oligogenic variant combinations. Nucleic Acids Res. 2019;47:W93\u20138. https:\/\/doi.org\/10.1093\/nar\/gkz437.","journal-title":"Nucleic Acids Res"},{"key":"2217_CR27","doi-asserted-by":"crossref","first-page":"1257601","DOI":"10.1126\/science.1257601","volume":"347","author":"J Menche","year":"2015","unstructured":"Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, Loscalzo J, et al. Uncovering disease-disease relationships through the incomplete interactome. Science. 2015;347:1257601.","journal-title":"Science"},{"key":"2217_CR28","doi-asserted-by":"publisher","first-page":"D977","DOI":"10.1093\/nar\/gkz930","volume":"48","author":"H Sun","year":"2019","unstructured":"Sun H, Guo Y, Lan X, Jia J, Cai X, Zhang G, et al. PhenoModifier: a genetic modifier database for elucidating the genetic basis of human phenotypic variation. Nucleic Acids Res. 2019;48:D977\u201382. https:\/\/doi.org\/10.1093\/nar\/gkz930.","journal-title":"Nucleic Acids Res"},{"key":"2217_CR29","doi-asserted-by":"crossref","first-page":"D993","DOI":"10.1093\/nar\/gkt937","volume":"42","author":"E Bragin","year":"2014","unstructured":"Bragin E, Chatzimichali EA, Wright CF, Hurles ME, Firth HV, Bevan AP, et al. DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation. Nucleic Acids Res. 2014;42:D993-1000.","journal-title":"Nucleic Acids Res"},{"key":"2217_CR30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343.","journal-title":"Nature"},{"key":"2217_CR31","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062\u20137.","journal-title":"Nucleic Acids Res"},{"key":"2217_CR32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2144\/000114492","volume":"62","author":"M Jalali Sefid Dashti","year":"2017","unstructured":"Jalali Sefid Dashti M, Gamieldien J. A practical guide to filtering and prioritizing genetic variants. Biotechniques. 2017;62:18\u201330.","journal-title":"Biotechniques"},{"key":"2217_CR33","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jval.2015.05.008","volume":"18","author":"T Richter","year":"2015","unstructured":"Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E, et al. Rare disease terminology and definitions\u2014a systematic global review: report of the ISPOR Rare Disease Special Interest Group. Value Heal J Int Soc Pharmacoeconomics Outcomes Res. 2015;18:906\u201314.","journal-title":"Value Heal J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"2217_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13023-017-0597-1","volume":"12","author":"SW Hee","year":"2017","unstructured":"Hee SW, Willis A, Tudur Smith C, Day S, Miller F, Madan J, et al. Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov. Orphanet J Rare Dis. 2017;12:44. https:\/\/doi.org\/10.1186\/s13023-017-0597-1.","journal-title":"Orphanet J Rare Dis"},{"key":"2217_CR35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13023-020-01639-7","volume":"16","author":"S Jason","year":"2021","unstructured":"Jason S, Maxime W, Anne-Sophie J. Assessing rare diseases prevalence using literature quantification. Orphanet J Rare Dis. 2021;16:139.","journal-title":"Orphanet J Rare Dis"},{"key":"2217_CR36","unstructured":"Orphanet. An online rare disease and orphan drug database. Copyright, INSERM 1997. Available at http:\/\/www.orpha.net [Internet]. \u00a9INSERM 1997. 2020. Available from: http:\/\/www.orpha.net."},{"key":"2217_CR37","unstructured":"Orphadata. Free access data from Orphanet. Copyright, INSERM 1997. Available at http:\/\/www.orphadata.org [Internet]. \u00a9INSERM 1997. 2020. Available from: http:\/\/www.orphadata.org."},{"key":"2217_CR38","doi-asserted-by":"publisher","first-page":"D1207","DOI":"10.1093\/nar\/gkaa1043","volume":"49","author":"S K\u00f6hler","year":"2021","unstructured":"K\u00f6hler S, Gargano M, Matentzoglu N, Carmody LC, Lewis-Smith D, Vasilevsky NA, et al. The human phenotype ontology in 2021. Nucleic Acids Res. 2021;49:D1207\u201317. https:\/\/doi.org\/10.1093\/nar\/gkaa1043.","journal-title":"Nucleic Acids Res"},{"key":"2217_CR39","doi-asserted-by":"publisher","first-page":"D498","DOI":"10.1093\/nar\/gkz1031","volume":"48","author":"B Jassal","year":"2020","unstructured":"Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2020;48:D498-503. https:\/\/doi.org\/10.1093\/nar\/gkz1031.","journal-title":"Nucleic Acids Res"},{"key":"2217_CR40","first-page":"3","volume":"7","author":"M Coll","year":"2017","unstructured":"Coll M, P\u00e9rez-Serra A, Mates J, Del Olmo B, Puigmul\u00e9 M, Fernandez-Falgueras A, et al. Incomplete penetrance and variable expressivity: hallmarks in channelopathies associated with sudden cardiac death. Biology (Basel). 2017;7:3.","journal-title":"Biology (Basel)"},{"key":"2217_CR41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/13993003.02277-2016","volume":"49","author":"MJ Johnson","year":"2017","unstructured":"Johnson MJ, Yorke J, Hansen-Flaschen J, Lansing R, Ekstr\u00f6m M, Similowski T, et al. Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J. 2017;49:5.","journal-title":"Eur Respir J"},{"key":"2217_CR42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0272-5231(21)00947-3","volume":"15","author":"WA Marinelli","year":"1994","unstructured":"Marinelli WA, Ingbar DH. Diagnosis and management of acute lung injury. Clin Chest Med. 1994;15:517\u201346.","journal-title":"Clin Chest Med"},{"key":"2217_CR43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1535-7511.2006.00100.x","volume":"6","author":"WD Shields","year":"2006","unstructured":"Shields WD. Infantile spasms: little seizures, BIG consequences. Epilepsy Curr. 2006;6:63\u20139.","journal-title":"Epilepsy Curr"},{"key":"2217_CR44","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1182\/blood.2019004216","volume":"135","author":"DB Sykes","year":"2020","unstructured":"Sykes DB, O\u2019Connell C, Schroyens W. The TEMPI syndrome. Blood. 2020;135:1199\u2013203. https:\/\/doi.org\/10.1182\/blood.2019004216.","journal-title":"Blood"},{"key":"2217_CR45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231\u20137.","journal-title":"Dis Model Mech"},{"key":"2217_CR46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00019053-200725030-00003","volume":"25","author":"DF Moore","year":"2007","unstructured":"Moore DF, Ries M, Forget EL, Schiffmann R. Enzyme replacement therapy in orphan and ultra-orphan diseases: the limitations of standard economic metrics as exemplified by Fabry-Anderson disease. Pharmacoeconomics. 2007;25:201\u20138.","journal-title":"Pharmacoeconomics"},{"key":"2217_CR47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1440-1789.2008.00891.x","volume":"28","author":"A Mahadevan","year":"2008","unstructured":"Mahadevan A, Vaidya SR, Wairagkar NS, Khedekar D, Kovoor JME, Santosh V, et al. Case of fulminant-SSPE associated with measles genotype D7 from India: an autopsy study. Neuropathology. 2008;28:621\u20136.","journal-title":"Neuropathology"},{"key":"2217_CR48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/GIM.0b013e318172838d","volume":"10","author":"S Das","year":"2008","unstructured":"Das S, Bale SJ, Ledbetter DH. Molecular genetic testing for ultra rare diseases: models for translation from the research laboratory to the CLIA-certified diagnostic laboratory. Genet Med. 2008;10:332\u20136.","journal-title":"Genet Med"},{"key":"2217_CR49","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ajhg.2017.04.003","volume":"100","author":"KM Boycott","year":"2017","unstructured":"Boycott KM, Rath A, Chong JX, Hartley T, Alkuraya FS, Baynam G, et al. International cooperation to enable the diagnosis of all rare genetic diseases. Am J Hum Genet. 2017;100:695\u2013705.","journal-title":"Am J Hum Genet"},{"key":"2217_CR50","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejmg.2010.12.001","volume":"54","author":"RCM Hennekam","year":"2011","unstructured":"Hennekam RCM. Care for patients with ultra-rare disorders. Eur J Med Genet. 2011;54:220\u20134.","journal-title":"Eur J Med Genet"},{"key":"2217_CR51","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/375178","volume":"72","author":"PL Beales","year":"2003","unstructured":"Beales PL, Badano JL, Ross AJ, Ansley SJ, Hoskins BE, Kirsten B, et al. Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am J Hum Genet. 2003;72:1187\u201399.","journal-title":"Am J Hum Genet"},{"key":"2217_CR52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","volume":"583","author":"E Turro","year":"2020","unstructured":"Turro E, Astle WJ, Megy K, Gr\u00e4f S, Greene D, Shamardina O, et al. Whole-genome sequencing of patients with rare diseases in a national health system. Nature. 2020;583:96\u2013102.","journal-title":"Nature"},{"key":"2217_CR53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13023-021-01741-4","volume":"16","author":"J Yang","year":"2021","unstructured":"Yang J, Dong C, Duan H, Shu Q, Li H. RDmap: a map for exploring rare diseases. Orphanet J Rare Dis. 2021;16:101.","journal-title":"Orphanet J Rare Dis"},{"key":"2217_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100887","author":"A Brodie","year":"2014","unstructured":"Brodie A, Tovia-Brodie O, Ofran Y. Large scale analysis of phenotype-pathway relationships based on GWAS results. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0100887.","journal-title":"PLoS ONE"},{"key":"2217_CR55","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1007\/978-1-4419-1698-3_1339","volume-title":"Encycl autism spectr disord","author":"T Fernandez","year":"2013","unstructured":"Fernandez T. Variable expressivity of genes. In: Volkmar FR, editor. Encycl autism spectr disord. New York: Springer; 2013. p. 3213. https:\/\/doi.org\/10.1007\/978-1-4419-1698-3_1339."},{"key":"2217_CR56","unstructured":"Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, Liaw A, et al. gplots: Various R programming tools for plotting data. R package version 3.1.0. https:\/\/cran.r-project.org\/package=gplots. 2020."},{"key":"2217_CR57","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu Z, Gu L, Eils R, Schlesner M, Brors B. circlize Implements and enhances circular visualization in R. Bioinformatics. 2014;30:2811\u20132.","journal-title":"Bioinformatics"},{"key":"2217_CR58","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gky1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419\u201326.","journal-title":"Nucleic Acids Res"},{"key":"2217_CR59","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41596-019-0128-8","volume":"14","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Huang X, Ebert D, Mills C, Guo X, et al. Protocol update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat Protoc. 2019;14:703\u201321.","journal-title":"Nat Protoc"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02217-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T17:37:52Z","timestamp":1700242672000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02217-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2217"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02217-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"22 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}